共 50 条
- [1] SINGLE -DOSE PHARMACOKINETICS AND TOLERABILITY OF ABT-089, A NOVEL NEURONAL NICOTINIC RECEPTOR PARTIAL AGONIST, IN HEALTHY VOLUNTEERSJOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1068 - 1068Xiong, HaoGarimella, TusharLocke, CharlesAwni, WalidDutta, Sandeep
- [2] PHARMACOKINETICS AND TOLERABILITY OF ABT-089, A NOVEL NEURONAL NICOTINIC RECEPTOR PARTIAL AGONIST, IN HEALTHY VOLUNTEERS, FOLLOWING MULTIPLE TWICE DAILY DOSESJOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1067 - 1067Garimella, TusharXiong, HaoLocke, CharlesAwni, WalidDutta, Sandeep
- [3] Efficacy and safety of the novel α4β2 neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover studyPsychopharmacology, 2012, 219 : 715 - 725George ApostolWalid Abi-SaabChristopher J. KratochvilLenard A. AdlerWeining Z. RobiesonLaura M. GaultYili L. PritchettDavid FeifelMichelle A. CollinsMario D. Saltarelli
- [4] Efficacy and safety of the novel α4β2 neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover studyPSYCHOPHARMACOLOGY, 2012, 219 (03) : 715 - 725Apostol, GeorgeAbi-Saab, WalidKratochvil, Christopher J.Adler, Lenard A.Robieson, Weining Z.Gault, Laura M.Pritchett, Yili L.Feifel, DavidCollins, Michelle A.Saltarelli, Mario D.
- [5] Safety, Tolerability, and Pharmacokinetics of Kukoamine B in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Phase I StudyADVANCES IN THERAPY, 2023, 40 (07) : 3186 - 3198Zhao, QianLiu, HongzhongWang, ZhenleiWang, TengCui, ChengWang, HuanhuanLi, LiliZhong, WenJiang, JiDong, KaiChen, ShuaiJin, ChunyanHu, Pei
- [6] Safety, Tolerability, and Pharmacokinetics of Kukoamine B in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Phase I StudyAdvances in Therapy, 2023, 40 : 3186 - 3198Qian ZhaoHongzhong LiuZhenlei WangTeng WangCheng CuiHuanhuan WangLili LiWen ZhongJi JiangKai DongShuai ChenChunyan JinPei Hu
- [7] A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteersJOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (01): : 30 - 40Wong, YNSimcoe, DHartman, LNLaughton, WBKing, SPMcCormick, GCGrebow, PE
- [8] A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED RISING DOSE STUDY TO INVESTIGATE THE TOLERABILITY AND PHARMACOKINETICS OF ETAMICASTAT FOLLOWING REPEATED ADMINISTRATION TO HEALTHY VOLUNTEERSJOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1094 - 1094Almeida, LuisRocha, Jose FranciscoNunes, TeresaFalcao, AmilcarSoares-da-Silva, Patricio
- [9] PHARMACOKINETICS, SAFETY AND TOLERABILITY OF SINGLE- AND MULTIPLE-DOSE ONCE-DAILY BARICITINIB IN CHINESE HEALTHY VOLUNTEERS - A RANDOMIZED PLACEBO-CONTROLLED STUDYANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 378 - 378Zhao, XiaPayne, ChristopherWang, FengCui, Yiming
- [10] Single- and Multiple-Dose Pharmacokinetics, Safety, and Tolerability of the Selective α7 Neuronal Nicotinic Receptor Agonist, ABT-107, in Healthy Human VolunteersJOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (04): : 512 - 526Othman, Ahmed A.Lenz, Robert A.Zhang, JunLi, JianlingAwni, Walid M.Dutta, Sandeep